
Gossamer Bio, Inc.
USD0.17
+0.00 (+2.07%)
CEO
Faheem Hasnain
IPO Date
2019-02-08
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$0.17
Prev. Close
$0.16
Day Low
$0.16
Day High
$0.17
52W Low
$0.14
52W High
$3.87
Market Cap
$0.04B
Volume
2.01M
| 23 Mar 2026 |
| Cantor Fitzgerald |
| Overweight |
| Neutral |
| downgrade |
| 6 Mar 2026 | HC Wainwright & Co. | Buy | Buy | maintain |
| 5 Mar 2026 | Oppenheimer | Outperform | Outperform | maintain |
| 24 Feb 2026 | Barclays | Overweight | Underweight | downgrade |
| 24 Feb 2026 | Leerink Partners | Outperform | Market Perform | downgrade |
| 24 Feb 2026 | Wedbush | Outperform | Neutral | downgrade |
| 22 Jan 2026 | HC Wainwright & Co. | Buy | Buy | maintain |